Clinical Trial Update: Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated adding carbogen and niacinamide to radiation therapy for bladder cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Carbogen (carbogen)
• Niacinamide (nicotinamide)

Snippet

Sponsor: Mount Vernon Cancer Centre at Mount Vernon Hospital | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED